![Amy Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Peterson
Director/Board Member at
Conquer Cancer Foundation of the American Society of Clinical
Net worth: 25 M $ as of 2026-08-30
Profile
Amy C.
Peterson is currently Secretary & Director at Conquer Cancer Foundation of the American Society of Clinical.
Formerly, Dr. Peterson was Associate Group Medical Director at Genentech, Inc. from 2005 to 2011, Vice President-Clinical Development at Medivation LLC (California) from 2011 to 2016, Chief Medical Officer-Immuno-Oncology at BeOne Medicines Ltd. from 2016 to 2019, President & Chief Operating Officer at CytomX Therapeutics, Inc. in 2022, and Chief Medical Officer & Executive Vice President at Exelixis, Inc. from 2023 to 2025.
Education includes a doctorate from Thomas Jefferson University and an undergraduate degree from Wesleyan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC. 0.19% | 2025-05-15 | 465,393 ( 0.19% ) | 25 M $ | 2026-08-30 |
Amy Peterson active positions
| Companies | Position | Start |
|---|---|---|
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Director/Board Member | - |
Former positions of Amy Peterson
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | 2025-08-28 |
| CYTOMX THERAPEUTICS, INC. | President | 2022-09-11 |
| BEIGENE LTD | Chief Tech/Sci/R&D Officer | 2019-01-22 |
| MEDIVATION INC | Corporate Officer/Principal | 2016-06-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2010-12-31 |
Training of Amy Peterson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Commercial Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Amy Peterson
